New Publication: Standardizing a human TBMNK cell assay across instrument platforms: a new framework for producing high-quality, AI-ready reference dataset
Slingshot Logo 2026 TM.svg

All Resources

Dive deeper into cell mimic controls and learn more about how they work, what they’re being used to achieve, and where they’re making the biggest impact.

Featured
Sep 26, 20262 min read

Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead Slingshot Bio into Its Next Chapter

Learn More
Dr. Nimisha Srivastava Appointed Chief Executive Officer at Slingshot Biosciences
FeaturedApr 30, 2026

TBNK Mimic as a Reliable Alternative to PBMC Controls for Consistent Immunophenotyping in Flow Cytometry

Flow cytometry-based immunophenotyping assays are widely used throughout the drug and diagnostic development life cycle to identify and quantify immune cell subsets, including T cells, B cells, and natural killer (NK) cells.

Read

TBNK Mimic as a Reliable Alternative to PBMC Controls for Consistent Immunophenotyping in Flow Cytometry

Featured
Dec 13, 20244 min read

Novel EGFR+ CD3+ Cell Mimics for Validating CAR-T Cell Enumeration by Flow Cytometry

Group 57 (1).png
Slingshot BiosciencesEditor
Read Case Study
thumbnail-13 1.jpg
Featured
Dec 13, 20243 min read

Development of a Ki-67 Expressing Cell Mimic for Assay Validation at Cerba Research

Group 57 (1).png
Slingshot BiosciencesEditor
Read Case Study
thumbnail-10 1.jpg
Featured
Oct 2, 20252 min read

Slingshot Biosciences Launches TruCytes™ Potency CD20 & CD34 Stem Cell Gating Controls, Standardizing Critical Readouts While Slashing Variability, Time, and Cost

Learn More
Slingshot Biosciences Launches TruCytes™ Potency CD20 & CD34 Stem Cell Gating Controls, Standardizing Critical Readouts While Slashing Variability, Time, and Cost
FeaturedApr 16, 2026

Cell Mimics as a Robust Quality Control Platform for Reliable CAR-T Potency Assays

Potency assays are critical for ensuring the quality, efficacy, and regulatory compliance of cell therapies, yet current methods are challenged by biological variability and the lack of standardized reference materials.

Read

Cell Mimics as a Robust Quality Control Platform for Reliable CAR-T Potency Assays

Published Article

Evaluation of a multiple myeloma synthetic cell mimic as an assay control for flow cytometry

Published Article

Evaluation of a multiple myeloma synthetic cell mimic as an assay control for flow cytometry

Oct 16, 2026

View
Poster

Synthetic CD34⁺ Stem Cell Mimics as a Stable and Reproducible Control for Flow Cytometry

Poster

Synthetic CD34⁺ Stem Cell Mimics as a Stable and Reproducible Control for Flow Cytometry

Oct 4, 2026

View
Application Note

Unmix with confidence: A smarter reference control for spectral unmixing

Application Note

Unmix with confidence: A smarter reference control for spectral unmixing

Sep 29, 2026

Read
introducing-viacomp-ultra-xt-amine .png
Group 57 (1).png
Slingshot Biosciences

Stabilizing the Activation-Exhaustion Continuum

Read Article4 min read
Published Article

Standardizing a human TBMNK cell assay across instrument platforms: a new framework for producing high-quality, AI-ready reference dataset

Published Article

Standardizing a human TBMNK cell assay across instrument platforms: a new framework for producing high-quality, AI-ready reference dataset

Sep 28, 2026

View
Dr. Nimisha Srivastava Appointed Chief Executive Officer at Slingshot Biosciences
Sep 26, 2026
Press ReleasesLeadership

Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead Slingshot Bio into Its Next Chapter

Learn More2 min read
Illustrated five-star review card on a dark starfield in Slingshot Bio brand colors
Group 57 (1).png
Slingshot Biosciences

Now Available: Product Reviews. Leave Yours Today!

Read Article3 min read
introducing-viacomp-ultra-xt-amine .png
Aug 17, 2026
Press Releases

Slingshot Bio Launches ViaComp® Ultra™ XT, the First Single-Vial Cell Mimic Control to accelerate Flow cytometry workflows

Learn More3 min read